TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in natriuresis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: SPID 0-12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech encoding characteristics development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood ammonia levels [NH3]
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TWSTRS-severity score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of pancreatic α-cell function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Presence of blood biomarkers correlating with α-cell function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Acceptability of Point of Care HbA1c Test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: First negative time of COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: faecal microbial alpha-diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of changes in clinical laboratory abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants at end of study
Endpoint domain: Mortality/survival
Primary endpoint: All cause unplanned hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Proportion of youth who initiate a text or schedule an assessment after scoring PQ-B positive
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of youth who advance to complete a clinical assessment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of youth who advance to care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hot Flash Frequency and Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score on the Yale-Brown Obsessive Compulsive Disorder (YBOCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of units of allogenic blood transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Five-times Sit-to-Stand Test (FTSST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of malignant tumors in the breast
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: The incidence and severity of adverse events (AEs) (%)
Endpoint domain: Adverse events/effects
Primary endpoint: Complete functional evaluation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Patients Improving ≥2 Steps on DRSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower oesophageal sphincter (LOS) pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastro-oesophageal junction (GOJ) distensibility index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oesophageal acid exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle power during the eccentric
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in sum of Omega-Score and Omega-Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reintubation at 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ventilatory free days (VFDs) from first spontaneous breathing trial to day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in decisional conflict scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in decision self-efficacy scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decision Satisfaction Scale Score at post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AAGL staging score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 5-year Local Recurrence-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Changes in uterine ecostructure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Trunk Control Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving EASI Score <= 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Fluoride Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Silver Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under Curve, Fluoride
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under Curve, Silver
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post operative Nausea
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in hepatitis B virus integration sites and count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Neuropsychiatric Inventory-Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient-Reported Outcomes Measurement Information System Global Health, 10-item
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Suicidal Behavior
Endpoint domain: Adverse events/effects
Primary endpoint: Chronic Subdural Hematoma (CSDH) recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Cardiac Cycle Efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of lower respiratory tract disease (LRTD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hepatic metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of safety outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of treatment-Emergent adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic performance of [18F]DPA-714 PET for glioma grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of Grade 3/4 neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Consumption of sevoflurane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of positive contacts
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants allocated as assigned
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Timed Up and Go (TUG) test (self- and fast-paced)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urine concentration defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Dynamic compliance of the ventilator-side lung
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: early detection of grade I-II adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of bortezomib in immune thrombocytopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Quick Disabilities of Arm, Shoulder, and Hand (quickDASH) Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage Consented
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage Retained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence to acupuncture treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability/Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in Cardiorespiratory Fitness (CRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suboptimal stent results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Real positive patients for screening techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain levels on HP-VAS after electroacupuncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HP-VAS during endodontic procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: E2C time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intestinal barrier
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: KCCQ-12 score variation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total Number of Positive Responses Across All Participants
Endpoint domain: Adverse events/effects
Primary endpoint: difference of positive rate between mNGS and Culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of distress related to loss of dignity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Other Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects With Functional Independence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Montgomery-Åsberg Depression Rating Scale-Self report version (MADRS-S)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Panic Disorder Severity Scale - Self Rated (PDSS-SR)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Liebowitz Social Anxiety Scale, self-report (LSAS-SR)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of fall
Endpoint domain: Adverse events/effects
Primary endpoint: Patient Function Improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Days to Recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Voxel-based dosimetry estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge Translation effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of bone affection by nutritional disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Uveitis control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of ACP injections
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Dose of ACP injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patterns of autofluorescence in parathyroid adenomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary PK endpoints FSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Primary PK endpoints hCG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of more severe DFUs presenting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Average percentage change of GIM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Total Lesions Count (TLC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Margin-positive rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of cells expressing LC3 protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microplastic presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ruminative Responses Scale (RRS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Chinese version of the Character-Digital Breadth Test score
Endpoint domain: Cognitive functioning
Primary endpoint: Antimicrobial peptide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Safety after NR082 treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of NR082 in study eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline serum TNF-α at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline serum IL-6 at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline serum IL-10 at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rectal sphincter function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stool continence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of anxiety disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of chronic fatigue syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention - Cognitive domain factor score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Office systolic blood pressure (OSBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic correlation between 3D-TRUBI and CT Brain scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Evaluation of potential adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: general safety
Endpoint domain: Adverse events/effects
Primary endpoint: Anti-MCPyV functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cost comparison
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intensity of axonal flare reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Family Outcome Measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Epidemiological Studies - Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Caregivers' empowerment to use different caregiving strategies
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Caregiver Knowledge Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Social Communication Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Area under the curve (AUC) for plasma concentration of MDZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of MDZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to maximum plasma concentration (Tmax) of MDZ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients accepting the Prevnar 20 Pneumococcal vaccine
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in UPDRS v-III Motor Examination Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Jebsen-Taylor Small Common Objects Functional Test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidences of Dose Limiting Toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in postoperative hemoglobin at 48hrs compared to preoperative baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants requiring allogeneic blood product transfusions
Endpoint domain: Adverse events/effects
Primary endpoint: Quantity of allogeneic blood product transfusion in number of packed red blood cells transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Evaluation of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Evaluation of urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of valid stool donations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of patients with post-induction hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain-DETECT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral manifestation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AVM regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in upper gastrointestinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: MDT change in mnemonic discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: TOUR change in recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Vital Signs Scale (V-Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurocognitive and neuropsychiatric complaints or disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cmax,ss of DWJ1567 and DWC202312
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCt of DWJ1567 and DWC202312
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to subjective improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Total CLDEQ-8 Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Inter-segmental coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cholesterol ester transfer protein activity (CETP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: paraoxonase-1 (PON-1) activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: peripheral blood mononuclear cells (PBMC) activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of PSMA-PET/CT imaging with positive findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Infusion-Related Reactions and Hypersensitivity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients adhering to prescribed dose
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 14-Panel Urine Drug Screen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Report of Drug Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of children who experience a drug related safety event during the CAB + RPV oral lead-in period
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of children who experience a grade 3 or higher adverse event during the CAB + RPV oral lead-in period
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of children who experience an SAE during the CAB + RPV oral lead-in period
Endpoint domain: Adverse events/effects
Primary endpoint: graft failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Conners' Parent Rating Scale-Revised, Long Version (CPRS-R-L)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent Agreement Between the Nurse UB-CAM Screen and the Reference Standard Delirium Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy Days at Home (HDAH)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Three Complications of Delirium
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of muscle fat infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Assessment Completion Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Amount of perceived pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in percentage incorporation of 2H2 palmitate into VLDL-TG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recurrence of incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Clinically Significant Change in Columbia Suicide Severity Rating Scale (C-SSRS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of SCB-2019 vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity of SCB-2019 vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Non-inferiority of SARS-CoV-2 nAb titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Estimated brain age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive maintenance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning